COVID-19 Updates
From the Journals
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Patients with immune-mediated inflammatory diseases have weaker vaccine-induced immunity to COVID but are able to build a humoral immune response...
From the Journals
Paxlovid reduces risk of COVID death by 79% in older adults
“Treatment with Paxlovid significantly reduces the risk of hospitalization and death from COVID-19.”
Conference Coverage
COVID-19 vaccine safe in patients with heart failure
There should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF; moreover, vaccines provide a survival benefit...
News from the FDA/CDC
COVID to blame as U.S. life expectancy falls
The overall drop took national life expectancy from 78.8 years in 2019 to 77 years in 2020.
From the Journals
Metformin fails as early COVID-19 treatment but shows potential
Metformin may merit further investigation for adults who are overweight or obese.
Latest News
Pfizer seeks approval for updated COVID booster
The new shots target both the original spike protein on the coronavirus and the spike mutations carried by BA.4 and BA.5.
News from the FDA/CDC
Children and COVID: New cases fall again, ED rates rebound for some
Once again, elementary schools and preschools will be full of children who are not vaccinated.
From the Journals
Regular physical activity may fight infection, illness from COVID: Study
Regular physical activity may help lower the risk of COVID-19 infection and its severity.
From the Journals
Most people with Omicron don’t know they’re infected
“The downside is that many people are likely spreading the virus unintentionally.”
From the Journals
COVID-19 may trigger irritable bowel syndrome
Estimates of the prevalence of gastrointestinal symptoms with COVID-19 have ranged as high as 60%.
News from the FDA/CDC
Children and COVID: ED visits and new admissions change course
Weekly cases dropped for the first time since early July.